The leadership transition comes at a pivotal moment for melanoma research. Since MRA's founding in 2007, the organization has ...
A new analysis of the EMPEROR-Preserved trial sheds light on the efficacy of the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin (Jardiance; Boehringer Ingelheim/Eli Lilly) in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results